PF-06651600 for the Treatment of Alopecia Areata

NCT03732807 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

718

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: PF-06651600 Induction Dose
DRUG: PF-06651600 Maintenance Dose #1
DRUG: PF-06651600 Maintenance Dose #2
DRUG: PF-06651600 Maintenance Dose #3
DRUG: Placebo

Sponsor

Pfizer